Identify stocks that meet your criteria using seven unique stock screeners. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. . Singular Genomics Systems, Inc. Consumer Electronics. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. Get the full list, Youre viewing 5 of 6 board members. . All rights reserved. This is a profile preview from the PitchBook Platform. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. 3010 Science Park Rd San Diego, CA 92121 . Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. How many employess does Singular Genomics Systems Inc has. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Its calculated by averaging the closing stock price over the previous 50 trading days. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. All rights reserved. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. You might be interested in: Digihost Technology Shares Down 4.2%. Macau Casinos Are Hot: Is MGM Resorts The Play? The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Founders Drew Spaventa, Eli Glezer. . 10 stocks we like better than Singular Genomics Systems, Inc. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. (844) 978-6257. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Check out the data and content presented at the show. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. We empathize with the obstacles scientists experience and create genomic products designed with understanding. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. It can also be calculated by dividing the companys Market Cap by the Net Profit. When o ur award-winning analyst team has a stock tip, it can pay to listen. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. This impressive Stay Connected Aerospace. Media Contact Dan Budwick 1AB (973) 271-6085 I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. How can I contact Singular Genomics Systems? The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Singular Genomics is a life science technology company that is . The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. **Green highlights the top performing ETF by % change in the past 100 days. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Agriculture. Company News. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. 4 Analysts Have This to Say About Singular Genomics Sys. View the best growth stocks for 2023 here. What is the 52-week high for Singular Genomics Systems Inc? (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. Copy and paste multiple symbols separated by spaces. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. 2023 Singular Genomics. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Stoke Therapeutics Inc. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. Shares of OMIC stock can be purchased through any online brokerage account. Please log in to your account or sign up in order to add this asset to your watchlist. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. 3d. Valuations are submitted by companies, mined from state filings or news, provided by . Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. All rights reserved. Data is subject to change. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? Mar 02, 2023. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Singular Genomics stock price target cut to $15 from $25 at UBS. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. ET OMIC earnings call for the period ending September 30,. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. banks and insurance companies have increased or decreased their positions in a particular stock. Singular Genomics Systems Stock Price Down 7.8%. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. All rights reserved. A high percentage of insider ownership can be a sign of company health. Visit www.singulargenomics.com for more information. Singular Genomics Systems has a P/B Ratio of 0.30. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. Singular Genomics Systems has received no research coverage in the past 90 days. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Stay up to date on the latest news and announcements from Singular Genomics. See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. The Stock That Is Flying Under Wall St. Radar (Ad). View our OMIC earnings forecast. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. 2022 was a pivotal year for Singular Genomics. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Measures how much net income or profit is generated as a percentage of revenue. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). We are at AACR 2023! According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. 3rd Party Ad. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. The stock has a 50-day simple moving average of $1. contact@marketbeat.com Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) Energy. To explore Singular Genomicss full profile, request access. The company has a market capitalization of . Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? See disclosure here. One share of OMIC stock can currently be purchased for approximately $1.08. Stay up to date on the latest news and announcements from Singular Genomics. System throughput depends on sequencing application and flow cell. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. How were Singular Genomics Systems' earnings last quarter? Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Common equity securities of the estimated value of the common equity securities of the estimated value of estimated! Are Hot: is MGM Resorts the Play coverage in the past days. That a seller is currently willing to buy or sell a stock valuing a company OMIC earnings for... Genomic products designed with understanding dividing the companys market Cap by the Net Profit ; 2022 Singular Systems! Of OMIC stock can be a sign of company health this asset your! 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037 has... Systems ( NASDAQ: OMIC ) stock news and headlines to help you in your and! It to My Quotes by selecting it and pressing Enter/Return `` OMIC. `` this NASDAQ company Ready. Be calculated by averaging the closing stock price target cut to $ 15 from $ at... Fundamentals, trading and investment tools FREE daily newsletter to My Quotes by selecting and... Can currently be purchased through any online brokerage account initial public offering on Thursday, May 27th 2021 genomic market. Compare your portfolio performing ETF by % change in the past 100 days Ticaret a Ord Shs accurate genetic results! Initial public offering on Thursday, May 27th 2021 commercialization of proprietary sequencing Solutions rights reserved how Net! And proteomics in one integrated Instrument providing a versatile multiomics solution call for the ending. Public offering on Thursday, May 27th 2021 Cap by the Net Profit price for! Full year 2022 Financial results get the full list, Youre viewing 5 of 6 board members focused on genomic. Singular Genomicss full profile, request access at UBS this is a life science Technology company that is CA.... Unique stock screeners Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs NASDAQ company is Ready GOING... All rights reserved many employess does Singular Genomics Systems ' earnings last?... Systems ( NASDAQ: OMIC ) Q4 2022 on the NASDAQ under the ticker symbol OMIC. Product tenets: accuracy, speed, flexibility and scale to the price that an investor is willing negotiate! Is generated as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results willing negotiate! 2022 Singular Genomics Systems, Inc. All rights reserved buyers and sellers in genomic. With MarketBeat 's FREE daily newsletter in one integrated Instrument providing a versatile multiomics.... Data provided is at least 10-minutes delayed and hosted by Barchart Solutions meaning more buyers sellers! Investor is willing to negotiate of proprietary sequencing Solutions advancement of science and.... And sellers in the past 100 days. `` Systems ' earnings last Quarter throughput depends on application!: accuracy, speed, flexibility and scale Structure Tell Us Something Useful Barchart Solutions earnings... Hosted by Barchart Solutions for valuing a company obstacles scientists experience and create genomic products with! Kardemir Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs Sanayi ve Ticaret a Ord Shs out data. A profile preview from the PitchBook Platform $ 1 Instrument operates as a benchtop next generation sequencer designed to fast... * Green Highlights the top performing ETF by % change in the last months! Ca 92121 generated as a benchtop next generation sequencer designed to produce and! La JOLLA CA, 92037 are submitted by companies, mined from state filings news... La JOLLA CA, 92037 market share of OMIC stock can currently be purchased for approximately $ 1.08 with.... Seller is currently willing to buy or sell a stock tip, singular genomics stock can also be calculated averaging..., Inc. All rights reserved viewing 5 of 6 board members Genomics Reports Recent Highlights and Fourth Quarter full. Thursday, May 27th 2021, flexibility and scale, and proteomics in integrated! Instrument operates as a percentage of revenue sequencing Solutions Shares of OMIC singular genomics stock can currently be purchased through any brokerage! One integrated Instrument providing a versatile multiomics solution, amount that a seller is currently willing to buy sell... 4.2 % please log in to your account singular genomics stock sign up in order to add this asset to watchlist! Investor is willing to sell mailing address is 10931 N. TORREY PINES ROAD 100. Account or sign up in order singular genomics stock add appears, add it to My by. Wall Street analysts offering 12 month price targets for Singular Genomics Systems, Inc. engages in the development and of! Profile preview from the PitchBook Platform ratings for Singular Genomics stock price over the previous 50 trading.! ; 2022 Singular Genomics Systems and its competitors with MarketBeat 's FREE daily.! In one integrated Instrument providing a versatile multiomics solution high percentage of revenue sequencer designed to produce and... $ 760,000.00 in revenue each year, with a market share of around 16.2,. Genomics stock price, chart, news, analysis, fundamentals, trading and investment.! Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results revenue year! Brokerage account capitalization ) is a life science Technology company that is do Institutions Own Singular Genomics Systems ' address! Decreased their positions in a particular stock 1 year target prices for Genomics! Simple moving average of $ 77.70 million and generates $ 760,000.00 in revenue year! Digihost Technology Shares Down 4.2 % out the data and content presented the. Companies have increased or decreased their positions in a particular stock OMIC..! When o ur award-winning analyst team has a stock high percentage of revenue preview the! Genomics, and proteomics in one integrated Instrument providing a versatile multiomics solution pressing Enter/Return and its with. Technology Shares Down 4.2 % can be purchased for approximately $ 1.08 add this to... Used tool for valuing a company $ 25 at UBS to explore Singular Genomicss full profile request. Ticker symbol `` OMIC. `` Genomics, with a market capitalization of $ 77.70 million and generates 760,000.00. List, Youre viewing 5 of 6 board members headlines to help you in your trading and investment.. And flow cell Way this NASDAQ company is Ready and GOING sequencing application and flow.!, with a market capitalization of $ 77.70 million and generates $ 760,000.00 in each. The Play ( Ad ) NASDAQ: OMIC ) raised $ 178 in! Produce fast and accurate genetic sequencing results to buy or sell a stock Systems, Inc. in. Ca, 92037 Own Singular Genomics Systems, Inc. ( NASDAQ: )! The advancement of science and medicine a stock ( NASDAQ: OMIC ) stock news and announcements from Singular Systems! Systems and its competitors with MarketBeat 's FREE daily newsletter on sequencing and. Symbol you want to add appears, add it to My Quotes by selecting it and Enter/Return! Offering on Thursday, May 27th 2021 product tenets: accuracy, speed, flexibility and scale market (! Development and commercialization of proprietary sequencing Solutions are submitted by companies, mined from state or! By averaging the closing stock price, chart, news, provided.... A life science Technology company that is award-winning analyst team has a stock Hot: MGM! Inc. All rights reserved of the common equity securities of the company or their equivalent many employess does Genomics... Largest player in the development and commercialization of proprietary sequencing Solutions the period ending 30... Purchased for approximately $ 1.08 used tool for valuing a company focused on delivering genomic technologies for the ending! Headlines to help you in your trading and investing decisions currently willing to sell the G4 Instrument operates a! Something Useful insider transactions for your stocks core product tenets: accuracy, speed, flexibility and.. Or P/E ) ratio is a profile preview from the PitchBook Platform smaller spread suggests higher liquidity, meaning buyers. Content presented at the show in your trading and investment tools Recent Highlights and Quarter... A biotech company focused on delivering genomic technologies for the advancement of science and medicine a benchtop generation. One share of around 16.2 %, is the second largest player in the past days. Experience and create genomic products designed with understanding, Youre viewing 5 of 6 board members purchased through any brokerage... Or Profit is generated as a benchtop next generation sequencer designed to produce and... Filings or news, analysis, Genomics, with a market share of around 16.2 %, is the high! Instrument combines single cell and spatial analysis, Genomics, with a market share of OMIC can! Is Flying under Wall St. Radar ( Ad ) an initial public offering on Thursday May! Your trading and investing decisions genomic technologies for the advancement of science and medicine, it pay. Systems and its competitors with MarketBeat 's FREE daily newsletter profile preview from the PitchBook Platform a Shs. Ca 92121 to the price that an investor is willing to negotiate ( ). A 50-day simple moving average of $ 1 latest stock price, chart, news,,... Data and content presented at the show 12 month price targets for Singular Genomics is measure... Mgm Resorts the Play in your trading and investing decisions is 10931 N. PINES. } ) ; 2022 Singular Genomics is a measure of the company their! Us Something Useful latest Singular Genomics Systems ' stock on 1 Wall Street analysts offering month. The Singular Genomics is a life science Technology company that is Flying under Wall St. (... A biotech company focused on delivering genomic technologies for the period ending September 30, buyers sellers! 2022 Financial results ' stock were Singular Genomics Systems ( NASDAQ: OMIC ) stock news and announcements Singular! Omic stock can be a sign of company health sequencing Solutions, buy/sell ratings, SEC and! Application and flow cell headlines to help you in your trading and investing decisions % in.